Hsa-mir-484 is a microRNA that is stably expressed in plasma and was chosen among other miRNAs for analysis using the BestKeeper software due to its limited intra-group variability expression [PMC8533962]. In a cohort study, hsa-mir-484 was found to be significantly different between multiple sclerosis (MS) patients and healthy subjects [PMC10062329]. Furthermore, the functional validation of hsa-mir-484 was demonstrated through an in vitro model that depicted the heterozygous deletion of MIR484, confirming its effect on miRNA expression and dysregulation of target genes [PMC9587983]. In silico analysis revealed that hsa-mir-484 is a predicted target of miR-1307, along with other miRNAs such as hsa-miR-193b-3p and hsa-miR-222-3p [PMC9578367].
a ----uc CUCA C AU -c a gcc gUCAGG GUC CCUCCCG aaa cccu a ||| |||||| ||| ||||||| ||| |||| cgg cggucc cag ggggggc uuu ggga a g uuuuuu ---- u cc ca u
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0002174 |
Description | Homo sapiens hsa-miR-484 mature miRNA |
Sequence | 8 - UCAGGCUCAGUCCCCUCCCGAU - 29 |
Evidence |
experimental
cloned [1-3], Northern [1] |
Database links | |
Predicted targets |
|